Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551-Reference-Cited by-同舟云学术

Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

Published:2017-06-27 Issue:9 Volume:33 Page:1715-1716
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Min T.¹²,Wali L.²,Williams D.M.²,Plummer E.²,Gurung A.²,Stephens J.W.²³

Affiliation:

1. Diabetes Research Group, School of Medicine, Swansea University, Swansea, Wales, UK

2. Department of Diabetes & Endocrinology, ABM University Health Board, Swansea, Wales, UK

3. Diabetes Research Group, School of Medicine, Grove Building, Swansea University, Swansea SA6 8NL, Wales, UK

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1336432

Reference5 articles.

1. Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes

2. Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

3. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years

4. Sodium-glucose cotransporter 2 inhibitors and renal function钠-葡萄糖共转运体2抑制剂与肾功能

5. NICE. Dapagliflozin in combination therapy for treating type 2 diabetes: TA288. 2013. Available at: http://www.nice.org.uk/guidance/ta288/resources/guidance-dapagliflozin-in-combination-therapy-for-treating-type2-diabetes-pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose co-transporter 2 inhibitors and serum uric acid;Current Medical Research and Opinion;2018-12-03

2. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice;Cellular Physiology and Biochemistry;2018